Progress in Antihypertensive Therapy with a Multiple-Action Drug

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Drugs

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/00003495-198800366-00005PMID 2908301
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vasodilating Mechanism and Response to Physiological Pressor Stimuli of Acute Doses of Carvedilol Compared with Labetalol, Propranolol and Hydralazine

  2012cited by this paper
• Haemodynamic Effects of New α-Blockers with Vasodilatory Properties in Essential Hypertension

  2012cited by this paper
• Pharmacology of Combined α-β-Blockade I

  2012cited by this paper
• Combined α- and β-Receptor Inhibition in the Treatment of Hypertension

  2012cited by this paper
• Sustained Limitation by Superoxide Dismutase of Canine Myocardial Injury Due to Regional Ischemia Followed by Reperfusion

  1988cited by this paper
• Effects of Oral Dilevalol Treatment on Renal Function

  1988cited by this paper
• Beta-Blockers in Clinical Practice

  1988cited by this paper
• The Hemodynamic Effects of Dilevalol in Patients with Mild Hypertension

  1988cited by this paper
• Effect of Carvedilol on Ambulatory Blood Pressure, Renal Hemodynamics, and Cardiac Function in Essential Hypertension

  1987cited by this paper
• Studies on the Antihypertensive Properties of Carvedilol, a Compound with &bgr;‐Blocking and Vasodilating Effects

  1987cited by this paper
• Effects of the Antihypertensive Dilevalol on Large Artery Compliance in Anesthetized Dogs

  1987cited by this paper
• Pharmacological Profile of Carvedilol, a Compound with &bgr;‐Blocking and Vasodilating Properties*

  1987cited by this paper
• Acute Hemodynamic Effects of the Vasodilating and &bgr;‐Blocking Agent Carvedilol in Comparison to Propranolol

  1987cited by this paper
• Evaluation of the Risk for Drug‐Induced Postural Hypotension in an Experimental Model: Investigations with Carvedilol, Prazosin, Labetalol, and Guanethidine*

  1987cited by this paper
• Studies on the Mode of Vasodilating Action of Carvedilol*

  1987cited by this paper
• Mechanism of the Vasodilatory Effect of Carvedilol in Normal Volunteers: A Comparison with Labetalol

  1987cited by this paper
• Efficacy of bucindolol in systemic hypertension.

  1987cited by this paper
• A randomized double-blind study of atenolol and celiprolol in mild to moderate hypertension.

  1986cited by this paper
• The additional properties of beta adrenoceptor blocking drugs.

  1986cited by this paper
• A comparison of celiprolol and atenolol in the treatment of hypertension: a placebo controlled double blind study.

  1985cited by this paper
• Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents?

  1985cited by this paper
• Intrinsic beta-sympathomimetic activity of dilevalol, R, R-isomer of labetalol.

  1985cited by this paper
• Sodium restriction lowers high blood pressure through a decreased response of the renin system--direct evidence using saralasin.

  1985cited by this paper
• INTRINSIC β-SYMPATHOMIMETIC ACTIVITY OF DILEVALOL, R, RISOMER OF LABETALOL

  1985cited by this paper
• Haemodynamic effects of carvedilol, a new beta-adrenoceptor blocker and precapillary vasodilator in essential hypertension.

  1984cited by this paper
• Pharmacology of combined alpha-beta-blockade. I.

  1984cited by this paper
• Pharmacology of Combined α-β-Blockade II

  1984cited by this paper
• Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.

  1984cited by this paper
• Combined alpha- and beta-receptor inhibition in the treatment of hypertension.

  1984cited by this paper
• Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.

  1984cited by this paper
• Vasodilation by medroxalol mediated by beta 2-adrenergic receptor stimulation.

  1983cited by this paper
• Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers.

  1983cited by this paper
• β and α‐Adrenoceptor Antagonism by Medroxalol in Healthy Volunteers: Relationship to Dose and Plasma Concentration

  1982cited by this paper
• How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.

  1982cited by this paper
• Prizidilol in Essential Hypertension: Long‐Term Effects on Plasma Volume, Extracellular Fluid Volume, and Central Hemodynamics at Rest and During Exercise

  1982cited by this paper
• Cardiovascular Properties of Medroxalol, A New Antihypertensive Drug

  1981cited by this paper
• Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927.

  1981cited by this paper
• Comparison of hypotensive, orthostatic and sympathetic inhibitory actions of antihypertensive drugs in rats.

  1981cited by this paper
• Comparative haemodynamic effects of labetalol, timolol, prazosin and the combination of tolamolol and prazosin.

  1979cited by this paper
• Comparative haemodynamic effects of labetalol, timolol, prazosin and the combination of tolamolol and prazosin.

  1979cited by this paper
• The clinical pharmacology of beta-adrenoceptor-blocking drugs.

  1976cited by this paper

• Impact of Virgin Coconut Oil and Carvedilol on Neurobehaviour, Apoptotic and Inflammatory Brain Markers in Doxorubicin Treated Mice

  2023cites this paper
• Therapeutics administered during ex vivo liver machine perfusion: An overview.

  2020cites this paper
• Exploration of 6,7-dimethoxyquinazoline derivatives as dual acting α1- and AT1-receptor antagonists: synthesis, evaluation, pharmacophore & 3D-QSAR modeling and receptor docking studies

  2016cites this paper
• Design and synthesis of 6,7-dimethoxyquinazoline analogs as multi-targeted ligands for α1- and AII-receptors antagonism.

  2013cites this paper
• Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation

  2010cites this paper